CAN vs CHM

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CAN

CANN GROUP FPO [CAN]

28LOW

CHM

CHIMERIC FPO [CHM]

32LOW

Score Breakdown

CAN CHM
Technical
35
58
Catalyst
51
55
Sentiment
50
50
Fundamental
37
6
Momentum
28
39
Risk Gate
22
27

Key Metrics

CAN Metric CHM
$9.6MMarket Cap$8.8M
2.7MAvg Volume (20d)8.4M
N/AShort InterestN/A
$0.03352-Week High$0.009
$0.00652-Week Low$0.001
+0.0%Daily Change+0.0%
$0.006Entry Price$0.002
+72.6%ROE-1291.0%
+130.3%Profit Margin-192.7%

Active Signals

CAN Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume surging at 3.8x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.7 quarters)
●Low P/S ratio (0.8x)
●Revenue in sharp decline (-30%)
●Piotroski F-Score weak (3/9, low-confidence approx)

CHM Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (0.9x)
●Revenue in sharp decline (-53%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised downward (-10pts)

Ask Scout AI to compare CAN and CHM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CAN Full Analysis → CHM Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).